Abstract:Identification of interactions between chemical compounds and proteins is crucial for various applications, including drug discovery, target identification, network pharmacology, and elucidation of protein functions. Deep neural network-based approaches are becoming increasingly popular in efficiently identifying compound-protein interactions with high-throughput capabilities, narrowing down the scope of candidates for traditional labor-intensive, time-consuming and expensive experimental techniques. In this study, we proposed an end-to-end approach termed SPVec-SGCN-CPI, which utilized simplified graph convolutional network (SGCN) model with low-dimensional and continuous features generated from our previously developed model SPVec and graph topology information to predict compound-protein interactions. The SGCN technique, dividing the local neighborhood aggregation and nonlinearity layer-wise propagation steps, effectively aggregates K-order neighbor information while avoiding neighbor explosion and expediting training. The performance of the SPVec-SGCN-CPI method was assessed across three datasets and compared against four machine learning- and deep learning-based methods, as well as six state-of-the-art methods. Experimental results revealed that SPVec-SGCN-CPI outperformed all these competing methods, particularly excelling in unbalanced data scenarios. By propagating node features and topological information to the feature space, SPVec-SGCN-CPI effectively incorporates interactions between compounds and proteins, enabling the fusion of heterogeneity. Furthermore, our method scored all unlabeled data in ChEMBL, confirming the top five ranked compound-protein interactions through molecular docking and existing evidence. These findings suggest that our model can reliably uncover compound-protein interactions within unlabeled compound-protein pairs, carrying substantial implications for drug re-profiling and discovery. In summary, SPVec-SGCN demonstrates its efficacy in accurately predicting compound-protein interactions, showcasing potential to enhance target identification and streamline drug discovery processes.

Exploring drug-protein interactions using the relationship between injection volume and capacity factor.

A Computerized Protein–protein Interaction Modeling Study of Ampicillin Antibody Specificity in Relation to Biosensor Development

Study on interaction between ampicillin antibody and detection interfering proteins by computer aided protein-protein docking for biosensor interesting

Computational Procedure for Predicting Excipient Effects on Protein-Protein Affinities

A Two-Pore Physiologically Based Pharmacokinetic Model to Predict Subcutaneously Administered Different-Size Antibody/Antibody Fragments

Emerging affinity methods for protein-drug interaction analysis

Drug-protein Binding of Danhong Injection and the Potential Influence of Drug Combination with Aspirin: Insight by Ultrafiltration LC–MS and Molecular Modeling

Progress in the Research of the Interaction between Drug and Serum Protein in vitro

MIN: Multi-channel Interaction Network for Drug-Target Interaction with Protein Distillation

Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins

Quantification of Protein Interaction Kinetics in a Micro Droplet

Current Experimental Methods for Characterizing Protein-Protein Interactions.

Experimental Methods for Characterizing Protein-Protein Interactions

Modeling the Interaction of Interferon Α-1B to Bovine Serum Albumin As a Drug Delivery System.

An end-to-end method for predicting compound-protein interactions based on simplified homogeneous graph convolutional network and pre-trained language model

Interformer: an Interaction-Aware Model for Protein-Ligand Docking and Affinity Prediction

In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

A Novel Strategy for Prediction of Human Plasma Protein Binding Using Machine Learning Techniques

Measurement of Protein-Protein Interaction Dynamics Using Microfluidics and Particle Diffusometry

An Integrated Transfer Learning and Multitask Learning Approach for Pharmacokinetic Parameter Prediction